title: Sirolimus and ACE-inhibitors: a note of caution.
authors.forename: Manuel
authors.initials: M
authors.lastname: Burdese
authors.forename: Maura
authors.initials: M
authors.lastname: Rossetti
authors.forename: Cesare
authors.initials: C
authors.lastname: Guarena
authors.forename: Valentina
authors.initials: V
authors.lastname: Consiglio
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Mezza
authors.forename: Giorgio
authors.initials: G
authors.lastname: Soragna
authors.forename: Massimo
authors.initials: M
authors.lastname: Gai
authors.forename: Giuseppe Paolo
authors.initials: GP
authors.lastname: Segoloni
authors.forename: Giorgina Barbara
authors.initials: GB
authors.lastname: Piccoli
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D017257:Ramipril / Q000009:adverse effects / Q000627:therapeutic use; D020123:Sirolimus / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007166:Immunosuppressive Agents; D017257:Ramipril; D020123:Sirolimus